Optimizing the Filtration of Liposomes Using Sterilizing-Grade Filters

References

1. 1.↵
   1. Chang H.-I.,
   2. Yeh M.-K.

   Clinical Development of Liposome-Based Drugs: Formulation, Characterization, and Therapeutic Efficacy. Int J Nanomed. 2012, 7, 49–60.

   OpenUrlWeb of ScienceGoogle Scholar
2. 2.↵
   1. Allen T. M.,
   2. Cullis P.

   Liposomal Drug Delivery Systems: From Concept to Clinical Applications. Adv. Drug Delivery Rev 2013, 65 (1), 36–48.

   OpenUrlCrossRefPubMedGoogle Scholar
3. 3.↵
   1. Carugo D.,
   2. Bottaro E.,
   3. Owen J.,
   4. Stride E.,
   5. Nastruzzi C.

   Liposome Production by Microfluidics: Potential and Limiting Factors. Sci. Rep. 2016, 6 (1), 25876.

   OpenUrlCrossRefGoogle Scholar
4. 4.↵
   1. Alavi M.,
   2. Karimi N.,
   3. Safaei M.

   Application of Various Types of Liposomes in Drug Delivery Systems. Adv. Pharm. Bull. 2017, 7 (1), 3–9.

   OpenUrlGoogle Scholar
5. 5.↵
   1. Pattni B. S.,
   2. Chupin V. V.,
   3. Torchilin V. P.

   New Developments in Liposomal Drug Delivery. Chem. Rev. 2015, 115 (19), 10938−10966.

   OpenUrlCrossRefPubMedGoogle Scholar
6. 6.↵
   1. Bulbake U.,
   2. Doppalapudi S.,
   3. Kommineni N.,
   4. Khan W.

   Liposomal Formulations in Clinical Use: An Updated Review. Pharmaceutics 2017, 9 (2), 12.

   OpenUrlCrossRefGoogle Scholar
7. 7.↵
   1. Wagner A.,
   2. Vorauer-Uhl K.

   Liposome Technology for Industrial Purposes. J. Drug Delivery 2011, 2011, 591325.

   Google Scholar
8. 8.↵
   1. Torchilin V. P.

   Recent Advances with Liposomes as Pharmaceutical Carriers. Nat. Rev. Drug Discovery 2005, 4 (2), 145–160.

   OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
9. 9.↵
   1. Sercombe L.,
   2. Veerati T.,
   3. Moheimani F.,
   4. Wu S. Y.,
   5. Sood A. K.,
   6. Hua S.

   Advances and Challenges of Liposome Assisted Drug Delivery. Front. Pharmacol. 2015, 6, 286.

   OpenUrlCrossRefPubMedGoogle Scholar
10. 10.↵
    1. Toh M.-R.,
    2. Chiu G. N. C.

    Liposomes as Sterile Preparations and Limitations of Sterilisation Techniques in Liposomal Manufacturing. Asian J. Pharm. Sci. 2013, 8 (2), 88–95.

    OpenUrlGoogle Scholar
11. 11.↵
    1. Huang Z.,
    2. Li X.,
    3. Zhang T.,
    4. Song Y.,
    5. She Z.,
    6. Li J.,
    7. Deng Y.

    Progress Involving New Techniques for Liposome Preparation. Asian J. Pharm. Sci. 2014, 9 (4), 176–182.

    OpenUrlGoogle Scholar
12. 12.↵
    1. Jahn A.,
    2. Vreeland W. N.,
    3. DeVoe D. L.,
    4. Locascio L. E.,
    5. Gaitan M.

    Microfluidic Directed Formation of Liposomes of Controlled Size. Langmuir 2007, 23 (11), 6289–6293.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
13. 13.↵
    1. Patil Y. P.,
    2. Jadhav S.

    Novel Methods for Liposome Preparation. Chem. Phys. Lipids 2014, 177, 8–18.

    OpenUrlCrossRefWeb of ScienceGoogle Scholar
14. 14.↵
    1. Franzen U.,
    2. Østergaard J.

    Physico-Chemical Characterization of Liposomes and Drug Substance–Liposome Interactions in Pharmaceutics Using Capillary Electrophoresis and Electrokinetic Chromatography. J. Chromatogr. A 2012, 1267 (7), 32–44.

    OpenUrlPubMedGoogle Scholar
15. 15.↵
    1. Smith M. C.,
    2. Crist R. M.,
    3. Clogston J. D.,
    4. McNeil S. E.

    Zeta Potential: A Case Study of Cationic, Anionic, and Neutral Liposomes. Anal. Bioanal. Chem. 2017, 409 (24), 5779–5787.

    OpenUrlGoogle Scholar
16. 16.↵
    1. Nimesh S.,
    2. Chandra R.

    1. Kumar A.,
    2. Dixit C. K.

    Methods for Characterization of Nanoparticles. In Advances in Nanomedicine for the Delivery of Therapeutic Nucleic Acids, Nimesh S., Chandra R., Eds.; Woodhead Publishing, 2017, pp 43–58.

    Google Scholar
17. 17.↵
    1. Laouini A.,
    2. Jaafar-Maalej C.,
    3. Limayem-Blouza I.,
    4. Sfar S.,
    5. Charcosset C.,
    6. Fessi H.

    Preparation, Characterization and Applications of Liposomes: State of the Art. J. Colloid Sci. Biotechnol. 2012, 1 (2), 147–168.

    OpenUrlCrossRefGoogle Scholar
18. 18.↵
    1. Willmott G. R.

    Tunable Resistive Pulse Sensing: Better Size and Charge Measurements for Submicrometer Colloids. Anal. Chem. 2018, 90 (5), 2987–2995.

    OpenUrlGoogle Scholar
19. 19.↵
    1. Duan Y.,
    2. Liu Y.,
    3. Li J.,
    4. Wang H.,
    5. Wen S.

    Investigation on the Nanomechanics of Liposome Adsorption on Titanium Alloys: Temperature and Loading Effects. Polymers 2018, 10 (4), 383.

    OpenUrlGoogle Scholar
20. 20.↵
    1. Et-Thakafy O.,
    2. Delorme N.,
    3. Gaillard C.,
    4. Mériadec C.,
    5. Artzner F.,
    6. Lopez C.,
    7. Guyomarc’h F.

    Mechanical Properties of Membranes Composed of Gel-Phase or Fluid-Phase Phospholipids Probed on Liposomes by Atomic Force Spectroscopy. Langmuir 2017, 33 (21), 5117–5126.

    OpenUrlGoogle Scholar
21. 21.↵
    1. Ramachandran S.,
    2. Quist A. P.,
    3. Kumar S.,
    4. Lal R.

    Cisplatin Nanoliposomes for Cancer Therapy: AFM and Fluorescence Imaging of Cisplatin Encapsulation, Stability, Cellular Uptake, and Toxicity. Langmuir 2006, 22 (19), 8156–8162.

    OpenUrlCrossRefPubMedGoogle Scholar
22. 22.↵
    1. Vorselen D.,
    2. MacKintosh F. C.,
    3. Roos W. H.,
    4. Wuite G. J. L.

    Competition between Bending and Internal Pressure Governs the Mechanics of Fluid Nanovesicles. ACS Nano 2017, 11 (3), 2628–2636.

    OpenUrlGoogle Scholar
23. 23.↵
    1. Folmsbee M.,
    2. Moussourakis M.

    Sterilizing Filtration of Liposome and Related Lipid-Containing Solutions: Enhancing Successful Filter Qualification. PDA J. Pharm. Sci. Technol. 2012, 66 (2), 161–167.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
24. 24.↵
    1. Folmsbee M.

    Evaluation of the Effect of the Volume Throughput and Maximum Flux of Low Surface-Tension Fluids on Bacterial Penetration of 0.2 Micron Rated Filters during Process-Specific Filter Validation Testing. PDA J. Pharm. Sci. Technol. 2015, 69 (2), 307–316.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
25. 25.↵
    Parenteral Drug Association Inc. PDA Technical Report No 26 (Revised 2008): Sterilizing Filtration of Liquids. PDA J. Pharm. Sci. Technol. 2008, 62 (S-5), 1–60.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
26. 26.↵
    U.S. Food and Drug Administration, Guidance for Industry: Sterile Drug Products Produced by Aseptic Processing—Current Good Manufacturing Practice. Center for Biologics Evaluation and Research, U.S. Department of Health and Human Services: Rockville, MD, 2004.

    Google Scholar
27. 27.↵
    1. Singh B.,
    2. Mundlamuri R.,
    3. Friese T.,
    4. Mundrigi A.,
    5. Handt S.,
    6. Loewe T.

    Benchmarking of Sterilizing-Grade Filter Membranes with Liposome Filtration. PDA J. Pharm. Sci. Technol. 2018, 72 (3), 223–235.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
28. 28.↵
    Microfluidics. How Our Microfluidizer Processors Work. Microfluidics Web site. https://www.microfluidics-mpt.com/microfluidics-technology/how-it-works (accessed March 31, 2020).

    Google Scholar
29. 29.↵
    1. Persson K. H.,
    2. Blute I. A.,
    3. Mira I. C.,
    4. Gustafsson J.

    Creation of Well-Defined Particle Stabilized Oil-in-Water Nanoemulsions. Colloids Surf., A 2014, 459, 48–57.

    OpenUrlGoogle Scholar
30. 30.↵
    1. Nguyen T. L.,
    2. Nguyen T. H.,
    3. Nguyen D. H.

    Development and In Vitro Evaluation of Liposomes Using Soy Lecithin to Encapsulate Paclitaxel. Int. J. Biomater. 2017, 2017, 8234712.

    OpenUrlGoogle Scholar
31. 31.↵
    1. Yuridian R.,
    2. Rosliana I.,
    3. Purwaningsih E. H.,
    4. Chaidir C.,
    5. Freisleben H.-J.,
    6. Pawitan J.

    Liposome Formulation of Soybean Phosphatidylcholine Extract from Argomulyo Variety Soy to Replace the Toxicity of Injectable Phosphatidylcholine Solution Containing Sodium Deoxycholate. Int. J. PharmTech Res. 2016, 9 (2), 166–175.

    OpenUrlGoogle Scholar
32. 32.↵
    1. Kulkarni S. B.,
    2. Betageri G. V.,
    3. Singh M.

    Factors Affecting Microencapsulation of Drugs in Liposomes. J. Microencapsulation 1995, 12 (3), 229–246.

    OpenUrlPubMedGoogle Scholar
33. 33.↵
    1. Elorza B.,
    2. Elorza M. A.,
    3. Sainz M. C.,
    4. Chantres J. R.

    Comparison of Particle Size and Encapsulation Parameters of Three Liposomal Preparations. J. Microencapsulation 1993, 10 (2), 237–248.

    OpenUrlPubMedGoogle Scholar
34. 34.↵
    1. Cagdas F. M.,
    2. Ertugral N.,
    3. Bucak S.,
    4. Atay N. Z.

    Effect of Preparation Method and Cholesterol on Drug Encapsulation Studies by Phospholipid Liposomes. Pharm. Dev. Technol. 2011, 16 (4), 408–414.

    OpenUrlPubMedGoogle Scholar
35. 35.↵
    1. Hermia J.

    Constant Pressure Blocking Filtration Laws—Application to Power-Law Non-Newtonian Fluids. Trans. Inst. Chem. Eng. 1982, 60 (3),183–187.

    OpenUrlGoogle Scholar
36. 36.↵
    1. Zydney A. L.,
    2. Ho C.-C.

    Scale-up of Microfiltration Systems: Fouling Phenomena and Vmax Analysis. Desalination 2002, 146 (1–3), 75–81.

    OpenUrlGoogle Scholar
37. 37.↵
    1. Badmington F.,
    2. Wilkins R.,
    3. Payne M.,
    4. Honig E. S.

    Vmax Testing for a Microfiltration Train Scale-Up in Biopharmaceutical Processing. Pharm. Technol. 1995, 19 (9), 64.

    OpenUrlGoogle Scholar
38. 38.↵
    1. Lujan H.,
    2. Griffin W. C.,
    3. Taube J. H.,
    4. Sayes C. M.

    Synthesis and Characterization of Nanometer-Sized Liposomes for Encapsulation and microRNA Transfer to Breast Cancer Cells. Int. J. Nanomed. 2019, 14, 5159–5173.

    OpenUrlGoogle Scholar
39. 39.↵
    1. Moghimi S. M.,
    2. Hunter A. C.,
    3. Murray J. C.

    Long-Circulating and Target Specific Nanoparticles: Theory to Practice. Pharmacol. Rev. 2001, 53 (2), 283–318.

    OpenUrlAbstract/FREE Full TextGoogle Scholar
40. 40.↵
    1. Danaei M.,
    2. Dehghankhold M.,
    3. Ataei S.,
    4. Hasanzadeh Davarani F.,
    5. Javanmard R.,
    6. Dokhani A.,
    7. Khorasani S.,
    8. Mozafari M. R.

    Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems. Pharmaceutics 2018, 10 (2), 57.

    OpenUrlGoogle Scholar
41. 41.↵
    1. Iritani E.,
    2. Katagiri N.,
    3. Inagaki G.

    Compression and Expansion Properties of Filter Cake Accompanied with Step Change in Applied Pressure in Membrane Filtration. Sep. Purif. Technol. 2018, 198, 3–9.

    OpenUrlGoogle Scholar
42. 42.↵
    1. Foley G.

    A Review of Factors Affecting Filter Cake Properties in Dead-End Microfiltration of Microbial Suspensions. J. Membr. Sci. 2006, 274 (1–2), 38–46.

    OpenUrlGoogle Scholar
43. 43.↵
    1. Morilla M. J.,
    2. Romero E. L.

    Ultradeformable Phospholipid Vesicles as a Drug Delivery System: A Review. Res. Reports Transdermal Drug Delivery 2015, 4, 55–69.

    OpenUrlGoogle Scholar
44. 44.↵
    1. Johnson J. M.,
    2. Ha T.,
    3. Chu S.,
    4. Boxer S. G.

    Early Steps of Supported Bilayer Formation Probed by Single Vesicle Fluorescence Assays. Biophys. J. 2002, 83 (6), 3371–3379.

    OpenUrlPubMedWeb of ScienceGoogle Scholar
45. 45.↵
    1. Schönherr H.,
    2. Johnson J. M.,
    3. Lenz P.,
    4. Frank C. W.,
    5. Boxer S. G.

    Vesicle Adsorption and Lipid Bilayer Formation on Glass Studied by Atomic Force Microscopy. Langmuir 2004, 20 (26), 11600–11606.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
46. 46.↵
    1. Richter R. P.,
    2. Bérat R.,
    3. Brisson A. R.

    Formation of Solid-Supported Lipid Bilayers: An Integrated View. Langmuir 2006, 22 (8), 3497–3505.

    OpenUrlCrossRefPubMedWeb of ScienceGoogle Scholar
47. 47.↵
    1. Reimhult E.,
    2. Zäch M.,
    3. Höök F.,
    4. Kasemo B.

    A Multitechnique Study of Liposome Adsorption on Au and Lipid Bilayer Formation on SiO2. Langmuir 2006, 22 (7), 3313–3319.

    OpenUrlPubMedGoogle Scholar
48. 48.↵
    1. Reimhult E.,
    2. Kasemo B.,
    3. Höök F.

    Rupture Pathway of Phosphatidylcholine Liposomes on Silicon Dioxide. Int. J. Mol. Sci. 2009, 10 (4), 1683–1696.

    OpenUrlPubMedGoogle Scholar
49. 49.↵
    1. Murrell M. P.,
    2. Voituriez R.,
    3. Joanny J.-F.,
    4. Nassoy P.,
    5. Sykes C.,
    6. Gardel M. L.

    Liposome Adhesion Generates Traction Stress. Nat. Phys. 2014, 10 (2), 163–169.

    OpenUrlGoogle Scholar